Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
about
SonothrombolysisThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingInduction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathwaysStructural basis of interaction between urokinase-type plasminogen activator and its receptorVitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophagesAng II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblastsUrokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.The diverse functions of Src family kinases in macrophages.Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer.Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells.Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents.Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia.Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
P2860
Q26781198-0B1AAA02-5392-4B27-BCDC-316257FD8CE2Q28257803-E4BFC9DE-A993-4D16-A572-267E543AB0EEQ33292446-9CFF5473-C691-4FF3-8B94-56D6F956A6D8Q36049729-F82745F1-A372-4D44-BEEF-EF0DF17461FCQ36237711-7F55C3F8-7B09-4EC7-8168-0B2CA1736C04Q36625153-554C729A-5224-48D4-BEF3-5A41D536FF05Q36749726-CB463337-E341-468D-8296-7B56A567B0B7Q36943056-E188FF77-6ABC-44DE-B313-CF8F688D4995Q37098597-ADA0A04A-547E-45C2-BBFF-7DD593E1FCEDQ37175318-B971B8DF-680D-4DE3-B5F3-23FF204EE493Q37245469-8C69EE5A-1C51-4C82-815F-859BD3311670Q40543455-50966C3B-5F09-4575-A2C7-063F08DF7C44Q41823150-4F8E77A0-9F23-4267-90BC-67627AA29491Q44901198-39C15C38-6F60-4300-AC4C-8A5EE48FE5A3Q46529169-BC5F6A6F-2EFF-48D1-BBD8-B4AD93242081Q46959722-575BFC25-8B6F-4746-9ADE-7C4FC450AE52Q57941761-D0918C3B-CFCF-4279-B426-A75275C45904
P2860
Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular and functional inter ...... tivator system with integrins.
@ast
Molecular and functional inter ...... tivator system with integrins.
@en
type
label
Molecular and functional inter ...... tivator system with integrins.
@ast
Molecular and functional inter ...... tivator system with integrins.
@en
prefLabel
Molecular and functional inter ...... tivator system with integrins.
@ast
Molecular and functional inter ...... tivator system with integrins.
@en
P2093
P2860
P356
P1433
P1476
Molecular and functional inter ...... tivator system with integrins.
@en
P2093
Manfred Schmitt
Sandra Hapke
Ute Reuning
Viktor Magdolen
P2860
P304
P356
10.1515/BC.2003.125
P577
2003-08-01T00:00:00Z